Given the hour — 4:30 a.m. in California, 7:30 a.m. in Boston — no one turned on their webcams.
About 180 executives and venture capitalists from large biotech companies and small start-ups alike dialed in to a WebEx call Monday. All were hoping the group chat would help them make big decisions about how to proceed with research, how to raise money from investors — essentially, how to run a biotech company in the time of coronavirus.
It was the sixth such virtual assembly; the group began meeting more than a month ago.
About the Author Reprints
Love to read your info